Vogenx Begins Phase 2b EMERGE Trial of Mizagliflozin
The randomized, double-blind, placebo-controlled study will evaluate two doses in patients with recurrent hypoglycemia following bariatric surgery.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
The randomized, double-blind, placebo-controlled study will evaluate two doses in patients with recurrent hypoglycemia following bariatric surgery.